← Lucas GC Ltd
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Profit or Loss | $39.8m | $36.4m | $78.2m | $40.1m | $9.9m | |
| Net Income (Loss) Attributable to Parent | — | $36.1m |
$10.9m
-69.73%
|
$5.5m
-50.18%
|
$1.4m
-74.33%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | $33.2m |
$10.9m
-67.08%
|
$5.5m
-50.18%
|
$9.8m
+79.45%
|
|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | $36.4m | $11.0m | $5.5m | $1.4m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | $269k | $72k | $41k | $10k | |
| Depreciation, Depletion and Amortization | — | $3.3m | $607k | $1.2m | $1.9m | |
| Depreciation | — | $3.3m | $4.3m | $8.5m | $13.2m | |
| Depreciation Expense | $1.5m | $3.3m | $4.3m | $8.5m | $13.2m | |
| Deferred Income Tax Expense (Benefit) | — | ($616k) | ($7.9m) | ($10.2m) | $2.5m | |
| Deferred tax assets, net | ($702k) | ($616k) | ($7.9m) | ($10.2m) | $2.5m | |
| Nonoperating Income (Expense) | — | $4.2m | $364k | $262k | ($1.0m) | |
| Other Nonoperating Income (Expense) | — | $4.1m | $490k | $484k | ($762k) | |
| Changes in operating assets and liabilities: | ||||||
| Increase (Decrease) in Accounts Receivable | — | $44.9m | ($9.0m) | $3.9m | ($4.1m) | |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | $91k | $1.6m | ($3.6m) | $254k | |
| Accounts receivable | ($22.9m) | ($44.9m) | $63.7m | ($28.6m) | $28.6m | |
| Accounts payable | $60.1m | ($16.1m) | ($51.8m) | $12.1m | ($11.3m) | |
| Income tax payables | $454k | ($393k) | ($6k) | — | ($16k) | |
| Accrued expenses and other current liabilities | $821k | ($2.3m) | $1.0m | ($597k) | ($2.2m) | |
| Prepaid expenses and other current assets | ($42k) | ($1.5m) | ($13k) | ($346k) | ($1.1m) | |
| Net Cash Provided by (Used in) Operating Activities | $60.6m |
($15.1m)
-124.94%
|
($5.1m)
+66.08%
|
$2.8m
+153.96%
|
$5.1m
+83.23%
|
|
| Cash flows from investing activities: | ||||||
| Purchases of software and equipment | ($24.1m) | ($13.7m) | ($12.1m) | ($44.7m) | ($83.2m) | |
| Fair vale gains on short-term investments | ($133k) | ($500k) | — | ($23k) | — | |
| Proceeds from Maturities of Investments | $26.8m | $82.3m | $4k | — | — | |
| Purchases of short-term investments | ($50.6m) | ($52.2m) | — | ($2.8m) | ($2.0m) | |
| Net cash (used in)/ provided by investing activities | ($47.8m) | $16.8m | ($12.1m) | ($79.9m) | ($107.3m) | |
| Net Cash Provided by (Used in) Investing Activities | — | $16.8m | ($1.7m) | ($11.0m) | ($15.3m) | |
| Cash flows from financing activities: | ||||||
| Proceeds from Debt Issuance | — | $9.1m | $63.3m | $90.3m | $1.8m | |
| Repayments of short-term borrowings | — | ($3.2m) | ($29.8m) | ($62.2m) | ($77.8m) | |
| Net Cash Provided by (Used in) Financing Activities | $26.5m |
$3.4m
-87.10%
|
$4.1m
+21.21%
|
$8.3m
+100.87%
|
$10.2m
+22.99%
|
|
| Net (decrease)/increase in cash, cash equivalents and restricted cash: | $39.2m | $5.3m | ($19.1m) | $1.4m | ($1.4m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $5.3m | ($2.7m) | $196k | ($193k) | |
| Cash, cash equivalents and restricted cash at the beginning of year | $44.0m | $49.3m | $30.2m | $31.7m | $30.3m | |
| Effect of Exchange Rate on Cash | ($81k) | $148k | ($8k) | $454k | ($1.1m) | |
| Additional Supplementary Disclosures | ||||||
| Additional Supplementary Disclosures | ||||||
| Additional Supplementary Disclosures | ||||||
| Supplemental disclosure of cash flow information: | ||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $30k | $129k | $249k | $384k | |
| Income Taxes Paid, Net | — | $415k | $1k | $23k | $27k | |
| Additional Financial Items | ||||||
| Gain (Loss) Related to Litigation Settlement | — | — | — | $1.2m | $1.2m | |
| General and Administrative Expense | — | $47.7m | $15.3m | $11.8m | $13.0m | |
| Income Tax Expense (Benefit) | — | ($595k) | ($1.1m) | ($1.4m) | $379k | |
| Operating Expenses | — | $183.6m | $49.4m | $45.1m | $47.5m | |
| Provision for Doubtful Accounts (CF) | $5.3m | $91k | $11.7m | ($3.6m) | $1.8m | |
| Advance to suppliers | ($59.6m) | $20.5m | ($125.4m) | $809k | $7.4m | |
| Contract liabilities | $34.4m | ($9.8m) | ($11.2m) | $2.4m | ($13.1m) | |
| Amounts due to related parties | $1.6m | $191k | $940k | $603k | — | |
| Purchases of development expenditures | — | — | — | ($32.5m) | ($2.3m) | |
| Payments of offering costs related to initial public offering ("IPO") | — | ($2.5m) | ($4.0m) | ($2.7m) | ($1.3m) | |
| Sale of public shares through public offering | — | — | — | $38.5m | $43.6m | |
| Income Tax Expense | — | $415k | $6k | $169k | $192k | |
| Interest Expense | — | $30k | $919k | $1.8m | $2.7m |